99 Episodio

  1. CSF proteomics in glioma

    Pubblicato: 21/03/2025

  2. Vorasidenib in IDH mutant glioma

    Pubblicato: 08/03/2025

  3. KL-50 in post TMZ MMR-deficient GBM

    Pubblicato: 22/02/2025

  4. Measurable disease per FET-PET vs MRI in GBM

    Pubblicato: 08/02/2025

  5. Pre-radiation chemotherapy in GBM

    Pubblicato: 20/01/2025

  6. cIMPACT-NOW Update 8: grading of meningiomas

    Pubblicato: 13/12/2024

  7. Residual tumor volume and survival after CCNU/TMZ in GBM

    Pubblicato: 24/11/2024

  8. Alterations in RNA splicing between meningioma DNA methylation groups

    Pubblicato: 08/11/2024

  9. The immune landscape of IDH mutant and IDHwt glioma

    Pubblicato: 25/10/2024

  10. Equity-driven applications of AI in neuro-oncology

    Pubblicato: 09/10/2024

  11. IDH mutant glioma across age groups

    Pubblicato: 20/09/2024

  12. Contemporary molecular prognostic signatures in glioma

    Pubblicato: 30/08/2024

  13. FDG PET in PCNSL

    Pubblicato: 09/08/2024

  14. TMZ and MGMT in elderly GBM patients

    Pubblicato: 12/07/2024

  15. IDH mutant glioma and IDH inhibitors

    Pubblicato: 05/07/2024

  16. Leptomeningeal disease, a SNO and ASCO review

    Pubblicato: 28/06/2024

  17. Cancer stems cell in GBM

    Pubblicato: 21/06/2024

  18. Drug delivery across the blood-brain barrier

    Pubblicato: 13/06/2024

  19. Gliomatosis cerebri in children

    Pubblicato: 24/05/2024

  20. Immunotherapy drives mesenchymal shift in GBM

    Pubblicato: 17/05/2024

1 / 5

Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.

Visit the podcast's native language site